微电生理
(688351)
| 流通市值：25.33亿 | | | 总市值：95.48亿 |
| 流通股本：1.25亿 | | | 总股本：4.71亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 338,885,399.15 | 269,109,754.97 | 232,794,654.03 | 534,934,783.76 |
| 应收票据及应收账款 | 74,654,927.37 | 73,962,789.29 | 50,864,397 | 60,088,173.39 |
| 应收账款 | 74,654,927.37 | 73,962,789.29 | 50,864,397 | 60,088,173.39 |
| 应收款项融资 | - | 10,524,934.46 | - | - |
| 预付款项 | 5,339,162.81 | 3,385,791.5 | 12,597,402.44 | 7,812,863.19 |
| 其他应收款合计 | 800,916.68 | 1,129,231.28 | 1,250,139.03 | 1,315,849.24 |
| 存货 | 133,268,848.84 | 127,835,766.93 | 130,592,317.76 | 125,428,958.08 |
| 其他流动资产 | 4,489,395.63 | 2,176,180.49 | - | - |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,529,026,592.14 | 1,577,514,062.85 | 1,572,753,795.81 | 1,552,294,967.94 |
| 非流动资产: | | | | |
| 长期应收款 | 4,685,827.26 | - | - | - |
| 长期股权投资 | 68,983,566.38 | 69,492,553.96 | 70,574,156.42 | 70,919,561.61 |
| 固定资产 | 179,421,271.62 | 92,385,640.6 | 90,719,929.65 | 92,327,692.41 |
| 使用权资产 | 7,541,635.76 | 15,630,596.87 | 17,683,869.61 | 20,008,094.62 |
| 无形资产 | 70,106,763.62 | 73,491,428.52 | 76,869,152.43 | 80,176,571.02 |
| 开发支出 | 50,933,078.16 | 43,658,095.73 | 29,367,145.73 | 25,918,158.42 |
| 长期待摊费用 | 4,529,586.57 | 5,113,141.15 | 5,570,011.98 | 6,326,229.7 |
| 递延所得税资产 | 1,248,211.22 | 2,512,009.11 | 2,860,416.39 | 3,204,074.66 |
| 其他非流动资产 | 1,402,133.7 | 13,885,441.39 | 1,709,673.7 | 209,073.7 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 388,852,074.29 | 316,168,907.33 | 295,354,355.91 | 299,089,456.14 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,917,878,666.43 | 1,893,682,970.18 | 1,868,108,151.72 | 1,851,384,424.08 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 62,616,558.08 | 49,570,025.9 | 54,380,065.73 | 56,755,798.9 |
| 其中：应付票据 | 20,788,280.57 | 12,953,627.88 | - | - |
| 应付账款 | 41,828,277.51 | 36,616,398.02 | 54,380,065.73 | 56,755,798.9 |
| 合同负债 | 5,413,167.09 | 4,831,438.98 | 3,763,262.19 | 3,871,890.02 |
| 应付职工薪酬 | 20,669,802.81 | 20,041,055.21 | 17,214,395.72 | 18,269,832.99 |
| 应交税费 | 3,198,014.24 | 907,274.17 | 3,235,462.16 | 4,488,444.55 |
| 其他应付款合计 | 21,051,447.66 | 23,172,627.92 | 16,388,607.3 | 17,248,281.18 |
| 一年内到期的非流动负债 | 4,505,051.75 | 9,118,492.88 | 9,002,870.91 | 8,265,641.42 |
| 其他流动负债 | 420,646.39 | 628,087.05 | 404,741.29 | 357,992.34 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 117,874,688.02 | 108,269,002.11 | 104,389,405.3 | 109,257,881.4 |
| 非流动负债: | | | | |
| 租赁负债 | 3,816,356.35 | 7,628,234.49 | 10,066,571.7 | 13,094,856.33 |
| 预计负债 | 9,393,778.37 | 8,762,962.81 | 8,095,737.83 | 7,842,582.86 |
| 递延收益 | 23,361,374.88 | 24,942,210.02 | 12,180,480.87 | 13,377,350.08 |
| 递延所得税负债 | 1,131,245.36 | 2,344,589.53 | 2,652,580.44 | 3,001,214.19 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 37,702,754.96 | 43,677,996.85 | 32,995,370.84 | 37,316,003.46 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 155,577,442.98 | 151,946,998.96 | 137,384,776.14 | 146,573,884.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 470,600,000 | 470,600,000 | 470,600,000 | 470,600,000 |
| 资本公积 | 1,271,037,033.58 | 1,268,340,851.52 | 1,267,672,893.65 | 1,266,474,562.13 |
| 其他综合收益 | 26.99 | 1,450.96 | 522.72 | - |
| 盈余公积 | 2,547,820.78 | 619,615.9 | - | - |
| 未分配利润 | 18,116,342.1 | 2,174,052.84 | -7,550,040.79 | -32,264,022.91 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,762,301,223.45 | 1,741,735,971.22 | 1,730,723,375.58 | 1,704,810,539.22 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,762,301,223.45 | 1,741,735,971.22 | 1,730,723,375.58 | 1,704,810,539.22 |
| 负债和股东权益合计 | 1,917,878,666.43 | 1,893,682,970.18 | 1,868,108,151.72 | 1,851,384,424.08 |
| 公告日期 | 2025-04-30 | 2025-03-28 | 2024-10-22 | 2024-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |